Patient records
Name: Margaret (pseudonym)
Age: 61
Nationality: Canadian
Diagnosis: IgG4-related disease (involving the pancreas, submandibular gland, and retroperitoneal lymph nodes), previously misdiagnosed as pancreatic cancer.
Treatment Hospital: Department of Rheumatology and Immunology, Peking Union Medical College Hospital
Case Theme: In the world of intractable diseases, the most agonizing part is often not the treatment itself, but the journey further and further down the path of treatment with a wrong diagnosis. Margaret's story is not about "curing," but about "correcting"—correcting a mistake that could have crushed a family.
1. A diagnosis defined as "cancer"
Two years ago, when Margaret began experiencing swelling in both eyelids and bilateral submandibular glands, and lost 10 kilograms in six months, CT and MRI scans at a local Canadian hospital gave a devastating diagnosis: a pancreatic mass, possibly pancreatic cancer, along with multiple enlarged retroperitoneal lymph nodes. This diagnosis was a bolt from the blue, and she immediately began chemotherapy. However, after two cycles, a contradictory picture emerged: tumor markers remained normal, while the enlarged "lymph nodes" and pancreatic mass showed no significant reduction in size. Her oncologist began to suspect that this might not be a typical malignant tumor, but the next step remained a mystery.
2. Our Value: Re-examining Clues Amidst the Fog of Diagnosis
When Margaret's daughter contacted us through remote counseling, her core concern was very clear and filled with anxiety: "We want to know, does my mother have cancer? If not, then what is it?"
As a health management company, we do not provide diagnoses, but we do provide "reassessment support for diagnostic direction." The first thing our case managers do is initiate a "re-investigation of the medical history."
First, involved re-organizing and structuring the clues. We compiled Margaret's scattered English medical records, pathology reports, imaging CDs, and lab reports from different hospitals over the past two years into a "Pre-Consultation Summary for Difficult Cases." During this process, our case manager noticed a crucial detail that had been overlooked: her serum IgG4 level was 15 times the upper limit of normal at the time of her initial examination. This indicator had been completely ignored in the context of cancer treatment.
Second, Precise matching with the "right experts." Based on the clues of "significantly elevated IgG4 levels + multi-organ swelling + negative tumor markers," we did not refer her to an oncology center, but instead matched her with an expert team from the Department of Rheumatology and Immunology at Peking Union Medical College Hospital . This team has extensive research experience in the field of "IgG4-related disease (IgG4-RD)." IgG4-RD is an immune-mediated disease that can affect multiple organs throughout the body, and its clinical manifestations are easily misdiagnosed as cancer.
Third, organized a consultation with specific questions in mind. We submitted the prepared preliminary summary and core question—"Is it IgG4-RD rather than pancreatic cancer?"—to the hospital specialists in advance. When Margaret and her family met with the specialists via video, they already had a thorough understanding of her condition and directly recommended a submandibular gland biopsy and more comprehensive IgG4-related testing, rather than repeating the previous imaging examinations.
3. During and after diagnosis: Comprehensive support from diagnosis to long-term management.
After Margaret arrived in China, we assisted her in undergoing a submandibular gland biopsy at Peking Union Medical College Hospital. The pathology results confirmed the experts' suspicions: extensive infiltration of IgG4-positive plasma cells, consistent with the diagnosis of IgG4-RD. She did not have cancer.
During the consultation: We assisted the expert team in developing an individualized hormone and immunosuppressant treatment plan for her, and arranged for a bilingual coordinator to accompany her throughout the process to ensure that she understood every detail of the treatment plan, especially the hormone tapering plan and possible side effects.
Post-diagnosis services and follow-up: IgG4-RD is a chronic disease requiring long-term management. We established an "IgG4-RD Chronic Disease Management File" for Margaret, and tracked her IgG4 levels, blood sugar, blood pressure, and bone density monthly via remote follow-up. Based on the follow-up results, we will provide early warnings of hormone-related diabetes, hypertension, or osteoporosis risks, and assist her in having quarterly remote follow-up consultations with Chinese experts to dynamically adjust the immunosuppressant dosage.
4. Therapeutic Effects and Insights
Three months into treatment, Margaret's pancreatic mass and enlarged lymph nodes shrank significantly, and her IgG4 levels returned to normal. In an email to us, she wrote, "Thank you for not letting me continue to receive the wrong treatment under the shadow of 'cancer.' You helped me find not only the right diagnosis, but also a long-term management plan. I now know that although my disease is rare, it is manageable."